Jefferson Health

Physician Profile

Alliric Willis, MD

Jefferson University Physician

Academic Title: Associate Professor

Surgery - Breast
Surgery - Endocrine
Surgery - Melanoma/Skin Cancer
Surgery - Oncology
Surgery - Thyroid/Parathyroid

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

1100 Walnut Street, 5th Floor
Philadelphia PA 19107
Phone: (215) 955-8666
Fax: (215) 627-3925
1100 Walnut Street
3rd Floor
Philadelphia PA 19107
Phone: (215) 955-8666
Fax: (215) 627-3925

Medical Services

Years in Practice


Board Certifications

  • Surgery

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital


Dr. Willis specializes in thyroid and parathyroid surgery, breast cancer and skin and soft tissue cancers/tumors. Member of the American College of Surgeons, American Society of Clinical Oncology, American Thyroid Association, Association for Academic Surgery, Philadelphia Academy of Surgery, Society of Surgical Oncology


  • University of Pennsylvania School of Medicine, Medical School


  • Washington University, St. Louis, Barnes-Jewish Hospital


  • Washington University, St. Louis, Barnes-Jewish Hospital


  • Yale-New Haven Hospital , New Haven, CT
  • Fox Chase Cancer Center

Recent Publications

African American Patients’ Psychosocial Support Needs and Barriers to Treatment: Patient Needs Assessment

Spindle cell carcinoma of the breast: A comprehensive analysis

Demographics, disparities, and outcomes in substernal goiters in the United States

Demographic risk factors impacting timely radiation therapy completion after breast conserving surgery

Examining rectal carcinoids in the era of screening colonoscopy: A surveillance, epidemiology, and end results analysis

Reply to G. Piessen et al

Gadd45a levels in human breast cancer are hormone receptor dependent

Association of race and socioeconomic status and outcomes of patients with rectal cancer

Complications of lymphadenectomy

Prognostic significance of signet ring gastric cancer

Does payer status matter in predicting penetrating trauma outcomes?

Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis

Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase

Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies

Parathyroid Carcinoma

Vascular Smooth Muscle Cell Migration: Current Research and Clinical Implications

Cyclic stretch induces the expression of vascular endothelial growth factor in vascular smooth muscle cells

The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis

Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis

Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent